Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05720533
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-09
First Post:
2023-01-31
Brief Title:
Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-31
First Submit QC Date:
January 31 2023
Study First Post Date:
2023-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-09
Last Update Post Date Type:
ACTUAL